Target species
Pigs.
Indications for use
For the active immunisation of pigs to prevent clinical signs of Erysipelas disease caused by all relevant Erysipelothrix rhusiopathiae serotypes (serotype 1 and 2).
Onset of immunity: 3 weeks
Duration of immunity: 6 months
Contraindications
None.
Special warnings for each target species
Vaccinate healthy animals only.
Special precautions for use
Not applicable.
Operator Warnings
In case of accidental self-injection, seek medical advice immediately and show the package leaflet or the label to the physician.
Adverse reactions
Pigs:
Very common (>1 animal / 10 animals treated): | Elevated temperature1. Injection site swelling2. |
Common (1 to 10 animals / 100 animals treated): | Reluctant to move3. |
Very rare (<1 animal / 10,000 animals treated, including isolated reports): | Hypersensitivity reaction. |
1 Transient increases in body temperature (0.5 °C) within 24 hours.
2 Mild and transient (diameter 1-10 mm) until 8 days after vaccination.
3 Transient.
Reporting adverse events is important. It allows continuous safety monitoring of a veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to either the marketing authorisation holder or its local representative or the national competent authority via the national reporting system. See the package leaflet for respective contact details.
Use during pregnancy, lactation or lay
Can be used during pregnancy and lactation.
Interactions
No information is available on the safety and efficacy of this vaccine when used with any other veterinary medicinal product except Porcilis Parvo vaccine. A decision to use this vaccine before or after any other veterinary medicinal product therefore needs to be made on a case by case basis.
Amounts to be administered and administration route
Intramuscular use.
Administer one dose of 2 ml by deep intramuscular injection behind the ear.
Initial vaccination:
A single dose of vaccine in pigs from an age of 10 weeks onwards.
Repeat vaccination 4 weeks later.
Booster vaccination:
Revaccinations should be twice a year.
Before using the vaccine allow it to reach room temperature (15 °C – 25 °C)
Shake the vial before and regularly during use.
Use sterile syringe and needles. Avoid introduction of contamination by multiple broaching.
Overdose
Reactions observed after administration of a double dose are not different from those observed after administration of a single dose.
Withdrawal period(s)
Zero days.